Related references
Note: Only part of the references are listed.Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal
Ai-Ling Li et al.
MOLECULAR PHARMACOLOGY (2019)
(R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes
Yingpeng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists
Amey Dhopeshwarkar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
C1′-Azacycloalkyl Hexahydrocannabinols
Thanh C. Ho et al.
JOURNAL OF ORGANIC CHEMISTRY (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
Marialessandra Contino et al.
FRONTIERS IN NEUROSCIENCE (2017)
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson et al.
PHARMACEUTICALS (2017)
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats
Leigh V. Panlilio et al.
PSYCHOPHARMACOLOGY (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues
Shashank Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
The use of cannabinoids as anticancer agents
Guillermo Velasco et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates
Brian D. Kangas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway
Amey Dhopeshwarkar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
3′-Functionalized Adamantyl Cannabinoid Receptor Probes
Go Ogawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Probing the Carboxyester Side Chain in Controlled Deactivation (-)-Δ8-Tetrahydrocannabinols
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
Elizabeth J. Rahn et al.
MOLECULAR PAIN (2014)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Cannabinoid receptors: nomenclature and pharmacological principles
Linda Console-Bram et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Elizabeth J. Rahn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9/β-1-Hydroxy-3-(1-hexyl-cyclobut-l-yl)hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Library of biphenyl privileged substructures using a safety-catch linker approach
Rune Severinsen et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2008)
Cannabinoid receptors: Where they are and what they do
K. Mackie
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cannabilactones: A novel class of CB2 selective agonists with peripheral analgesic activity
Atmaram D. Khanolkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
C1′-cycloalkyl side chain pharmacophore in tetrahydrocannabinols
Demetris P. Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The endocannabinoid system: Current pharmacological research and therapeutic possibilities
KO Jonsson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'
DP Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
DA Horton et al.
CHEMICAL REVIEWS (2003)
Convenient procedure of Horner-Wadsworth-Emmons olefination for the synthesis of simple and functionalized α,β-unsaturated nitriles
A Lattanzi et al.
TETRAHEDRON LETTERS (2003)
Novel 1′,1′-chain substituted Δ8-tetrahydrocannabinols
DP Papahatjis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
A new ring-forming methodology for the synthesis of conformationally constrained bioactive molecules
DP Papahatjis et al.
CHEMISTRY LETTERS (2001)
Privileged molecules for protein binding identified from NMR-based screening
PJ Hajduk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
